Recent News

• 06.04.2025 - Jefferies Global Healthcare Conference
• 06.04.2025 - Jefferies Global Healthcare Conference
• 06.02.2025 - Verastem Oncology R&D Investor Event at ASCO 2025 Annual Meeting
• 06.02.2025 - Verastem Oncology R&D Investor Event at ASCO 2025 Annual Meeting
• 06.02.2025 - Verastem Oncology R&D Investor Event at ASCO 2025 Annual Meeting
• 06.02.2025 - Verastem Oncology R&D Investor Event at ASCO 2025 Annual Meeting
• 06.02.2025 - Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1 Study in China of GFH375 (VS-7375), an Oral KRAS G12D (ON/OFF) Inhibitor
• 06.02.2025 - Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1 Study in China of GFH375 (VS-7375), an Oral KRAS G12D (ON/OFF) Inhibitor
• 05.28.2025 - Verastem Oncology to Present at the Jefferies Global Healthcare Conference
• 05.28.2025 - Verastem Oncology to Present at the Jefferies Global Healthcare Conference

Recent Filings

• 06.02.2025 - EX-99.1 EX-99.1
• 06.02.2025 - 8-K Current report
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 4 Statement of changes in beneficial ownership of securities